CARTA CLÍNICA
Fenómeno de Raynaud secundario a un colirio antiglaucomatoso
Raynaud's phenomenon secondary to anti-glaucoma eye drops
R. Bugarín-Gonzáleza,
, M. Portela-Romerob, M.C. Maceira-Rozasa, P. López-Vázquezc, C. Bugarín-Dizd
Autor para correspondencia
a Unidad de Asesoramiento Científico-técnico, avalia-t, Axencia de Coñecemento en Saúde (ACIS), Servicio Gallego de Salud, Santiago de Compostela, España
b Estrutura Organizativa de Xestión Integrada (EOXI) de Santiago de Compostela, Servicio Gallego de Salud, Santiago de Compostela, A Coruña, España
c Consellería de Sanidad, Xunta de Galicia, Santiago de Compostela, España
d King's College, Londres, Reino Unido
Leído
14496
Vecesse ha leído el artículo
1252
Total PDF
13244
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 6 | 24 |
| 2025 11 | 79 | 22 | 101 |
| 2025 10 | 104 | 8 | 112 |
| 2025 9 | 64 | 16 | 80 |
| 2025 8 | 58 | 29 | 87 |
| 2025 7 | 48 | 12 | 60 |
| 2025 6 | 48 | 15 | 63 |
| 2025 5 | 59 | 3 | 62 |
| 2025 4 | 89 | 15 | 104 |
| 2025 3 | 65 | 11 | 76 |
| 2025 2 | 88 | 5 | 93 |
| 2025 1 | 91 | 5 | 96 |
| 2024 12 | 53 | 3 | 56 |
| 2024 11 | 32 | 6 | 38 |
| 2024 10 | 38 | 8 | 46 |
| 2024 9 | 32 | 21 | 53 |
| 2024 8 | 27 | 11 | 38 |
| 2024 7 | 40 | 15 | 55 |
| 2024 6 | 31 | 14 | 45 |
| 2024 5 | 45 | 15 | 60 |
| 2024 4 | 26 | 8 | 34 |
| 2024 3 | 57 | 11 | 68 |
| 2024 2 | 105 | 29 | 134 |
| 2024 1 | 136 | 32 | 168 |
| 2023 12 | 113 | 24 | 137 |
| 2023 11 | 202 | 29 | 231 |
| 2023 10 | 238 | 30 | 268 |
| 2023 9 | 96 | 11 | 107 |
| 2023 8 | 104 | 9 | 113 |
| 2023 7 | 141 | 3 | 144 |
| 2023 6 | 143 | 3 | 146 |
| 2023 5 | 203 | 1 | 204 |
| 2023 4 | 191 | 3 | 194 |
| 2023 3 | 184 | 7 | 191 |
| 2023 2 | 185 | 5 | 190 |
| 2022 1 | 171 | 5 | 176 |
| 2022 12 | 126 | 15 | 141 |
| 2022 11 | 151 | 12 | 163 |
| 2022 10 | 125 | 11 | 136 |
| 2022 9 | 157 | 16 | 173 |
| 2022 8 | 131 | 9 | 140 |
| 2022 7 | 115 | 10 | 125 |
| 2022 6 | 140 | 23 | 163 |
| 2022 5 | 144 | 14 | 158 |
| 2022 4 | 155 | 18 | 173 |
| 2022 3 | 212 | 19 | 231 |
| 2022 2 | 186 | 9 | 195 |
| 2021 1 | 262 | 18 | 280 |
| 2021 12 | 153 | 29 | 182 |
| 2021 11 | 164 | 11 | 175 |
| 2021 10 | 174 | 12 | 186 |
| 2021 9 | 124 | 8 | 132 |
| 2021 8 | 187 | 11 | 198 |
| 2021 7 | 181 | 9 | 190 |
| 2021 6 | 113 | 10 | 123 |
| 2021 5 | 167 | 13 | 180 |
| 2021 4 | 327 | 12 | 339 |
| 2021 3 | 237 | 12 | 249 |
| 2021 2 | 187 | 11 | 198 |
| 2020 1 | 193 | 11 | 204 |
| 2020 12 | 126 | 9 | 135 |
| 2020 11 | 89 | 14 | 103 |
| 2020 10 | 79 | 16 | 95 |
| 2020 9 | 119 | 14 | 133 |
| 2020 8 | 113 | 11 | 124 |
| 2020 7 | 104 | 6 | 110 |
| 2020 6 | 101 | 11 | 112 |
| 2020 5 | 112 | 7 | 119 |
| 2020 4 | 118 | 11 | 129 |
| 2020 3 | 116 | 13 | 129 |
| 2020 2 | 161 | 9 | 170 |
| 2020 1 | 200 | 14 | 214 |
| 2019 12 | 178 | 11 | 189 |
| 2019 11 | 186 | 3 | 189 |
| 2019 10 | 211 | 5 | 216 |
| 2019 9 | 329 | 5 | 334 |
| 2019 8 | 141 | 1 | 142 |
| 2019 7 | 164 | 22 | 186 |
| 2019 6 | 267 | 59 | 326 |
| 2019 5 | 364 | 45 | 409 |
| 2019 4 | 229 | 22 | 251 |
| 2019 3 | 92 | 17 | 109 |
| 2019 2 | 170 | 2 | 172 |
| 2019 1 | 194 | 3 | 197 |
| 2018 12 | 172 | 9 | 181 |
| 2018 11 | 205 | 13 | 218 |
| 2018 10 | 164 | 8 | 172 |
| 2018 9 | 209 | 10 | 219 |
| 2018 8 | 186 | 3 | 189 |
| 2018 7 | 132 | 3 | 135 |
| 2018 6 | 174 | 1 | 175 |
| 2018 5 | 146 | 1 | 147 |
| 2018 4 | 60 | 0 | 60 |
| 2018 3 | 77 | 3 | 80 |
| 2018 2 | 67 | 3 | 70 |
| 2018 1 | 30 | 0 | 30 |
| 2017 12 | 80 | 2 | 82 |
| 2017 11 | 12 | 4 | 16 |
| 2017 10 | 1 | 0 | 1 |
| 2017 9 | 2 | 0 | 2 |
| 2017 8 | 2 | 1 | 3 |
| 2017 7 | 2 | 0 | 2 |
| 2017 6 | 1 | 3 | 4 |
| 2017 5 | 2 | 1 | 3 |
| 2017 4 | 3 | 3 | 6 |
| 2017 3 | 10 | 33 | 43 |
| 2017 2 | 10 | 5 | 15 |
| 2016 1 | 6 | 3 | 9 |
| 2016 12 | 2 | 11 | 13 |
| 2016 11 | 3 | 10 | 13 |
| 2016 10 | 8 | 19 | 27 |
Mostrar todo
